Drug product
Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 90 tablets per bottle. [Brand, NDC] NDC Equate: 49035-608-75; NDC Up & Up: 11673-023-75
D-1024-2020
Product summary
- Event
- Event 84127
- Status
- Terminated
- Classification
- Class II
- Quantity
- Unavailable
- Official record key
drug-enforcement:D-1024-2020
Official wording
Reason: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Code information: Lots: 8EE1702, 8EE1703, 8EE1704, 8FE1724, 8GE1942, 8HE1396, 8HE1397, 8JE2156, 8KE2521, 8KE2523, 8LE2255, 8LE2665, 8LE2668, 9AE2541, 9AE2542, 9AE2543, 9BE2993, 9BE2994, 9BE2995, 9CE3735, 9CE3736, 9DE3108, 9DE3109, 9DE3110, 9EE2872, 9EE2880, 9FE3273, 9FE3276, 9GE2978, 9GE2979, 9HE3437, 9HE3438
Distribution pattern: Nationwide USA
Derived failure modes
-
Foreign material or chemical contamination
impurity N-nitrosodimethylamine
-
Manufacturing or process control
CGMP Deviation